|
Volumn 43, Issue 1119, 2001, Pages 103-105
|
Drugs for HIV infection
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE;
AMPRENAVIR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DAPSONE;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
INDINAVIR;
KETOCONAZOLE;
LAMIVUDINE;
LAMIVUDINE PLUS ZIDOVUDINE;
LOPINAVIR;
LOPINAVIR PLUS RITONAVIR;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
TENOFOVIR;
TENOFOVIR DISOPROXIL;
UNCLASSIFIED DRUG;
VIDEX EC;
ZALCITABINE;
ZIDOVUDINE;
ANEMIA;
COMBINATION CHEMOTHERAPY;
CONFUSION;
DRUG ABSORPTION;
DRUG COST;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
FATIGUE;
HEADACHE;
HEPATITIS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LACTIC ACIDOSIS;
MALAISE;
MYOPATHY;
NAUSEA;
NEUTROPENIA;
PREGNANCY;
SENSORY NEUROPATHY;
SHORT SURVEY;
STEATOSIS;
VOMITING;
DELAVIRDINE;
DIDANOSINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
NELFINAVIR;
NEVIRAPINE;
OXAZINES;
REVERSE TRANSCRIPTASE INHIBITORS;
SAQUINAVIR;
STAVUDINE;
ZIDOVUDINE;
|
EID: 0035956226
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (7)
|
References (0)
|